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1.  Introduction 
Neurocognitive deficits and the expression of 
symptoms in schizophrenia contribute to the chronic 
disability in psychological, social and occupational 
functioning experienced by sufferers.[1-3] The relative 
contribution of symptoms versus neurocognition is 
complex and still not fully understood.  Some studies 
indicate the primacy of neurocognitive variables over 
symptoms[4] whereas others support a mediation model 
whereby symptoms at least partially mediate the 
relationship between neurocogntion and outcome.[5]
At least seven areas of neurocognitive functioning 
(speed of processing, attention/vigilance, working 
memory, verbal learning, visual learning, and reasoning 
and problem solving) are commonly impaired in 
schizophrenia.[6]  Verbal memory and working memory 
deserve special consideration for neurobiological 
reasons and because of their relationship to functional 
outcome.[7] A 2004 review and meta-analysis by Green 
and colleagues[4] concluded that immediate (working) 
and secondary verbal memory are the most potent 
neurocognitive predictors of functional outcome. 
These findings have been confirmed by a more recent 
meta-analysis[5] and a large scale study of older patients 
with schizophrenia.[8] However, not all research has 
confirmed this relationship.  For example, Addington 
and colleagues[9] found no significant associations 
between cognitive measures and social functioning. 
One study[10] found that secondary memory and verbal 
IQ correlated with some outcome measures, but 
immediate memory did not.
Functional outcome has been measured in a variety 
of ways including activities of daily living and general 
community functioning.  It can also be assessed in 
terms of success in rehabilitation programs or in 
terms of general problem solving abilities.   Hsieh and 
colleagues[11] recently studied the relationship between 
performance and neurocognition in a Taiwanese 
sample using a battery of neurocognitive variables and 
functional measures, including the Personal and Social 
Performance scale (PSP) and the Activities of Daily 
Living (ADL) scale.  They found significant correlations 
between verbal memory performance and total PSP 
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score.  Baseline measures of verbal memory have 
been found to predict functional outcomes from one 
month[12] up to seven years.[13] Current performance on 
these neurocognitive measures has also been found to 
be a strong predictor of functional disability in people 
with schizophrenia who are symptomatically stable;[14] 
this recent study found that working memory predicted 
work and educational functioning while verbal memory 
predicted skills at independent living.  
Symptoms in schizophrenia also have a significant 
role to play in predicting functional outcomes.  The three 
factor model of positive, negative and disorganised 
symptoms in schizophrenia is currently the most widely 
applied[15-17] although this structure is not universally 
accepted.[18] Recent studies emphasize the role of 
negative symptoms as predictors of poorer social and 
occupational outcomes.[5,13,14] At least one study found 
that disorganised symptoms predict social functioning.[19] 
There has been limited research support for the role of 
positive symptoms as predictors of functional outcomes, 
though one older study[20] reported that baseline levels 
of positive symptoms—especially thought disturbance—
predicted poor outcomes for patients with chronic 
schizophrenia.  
The relationship between symptoms and neuro-
cognition is complex.  Generally, in cross-sectional 
studies negative symptoms have produced the strongest 
correlations with neurocognitive deficits.[5] Prominent 
negative symptoms have been linked to poorer 
performance on verbal memory tasks[21] and on verbal 
working memory.[22] There is some support for the 
role of disorganised thinking or behaviour in impairing 
neurocognitive performance, particularly on complex 
executive processes such as working memory.[23] Less 
convincing is the evidence that positive symptoms are 
related to impaired neurocognitive abilities. One study 
found increased perseverative errors and a bias towards 
false alarms on a list learning task,[24] but a recent meta-
analysis[5] found virtually no relationship.
The aim of the current study is to investigate the 
relationships among clinical, cognitive and functional 
variables in a sample of Chinese inpatients with 
schizophrenia.  We were particularly interested in 
examining the relationship between these variables 
in this population before they were clinically stable 
as most work to date has examined how baseline 
neurocognit ion and symptoms predict  future 
functioning.  We hypothesized that measures of 
social functioning would be more strongly correlated 
to cognitive measures of verbal memory and verbal 
working memory than to measures of psychiatric 
symptoms. Further, we hypothesized that the measures 
of psychomotor poverty (negative) symptoms would 
be more strongly correlated to cognitive performance 




The enrolment of participants is shown in Figure 1. 
The study was conducted at two acute-care male wards 
Figure 1.  Flowchart of enrolment in the study
 
56 male patients with a current diagnosis of schizophrenia from two 
inpatient wards at the Shanghai Mental Health Centre from October 
2010 to January 2011 being treated with antipsychotic medication 
 
40 completed assessments: 
 Positive and Negative Symptom Scale (PANSS) 
 Clinical Global Impression Scale (CGI) 
 Personal and Social Performance Scale (PSP) 
 Letter-Number Sequencing Task (Chinese version) 
 Hong Kong List Learning Test 
19 had low scores 
on cognitive tasks 
51 consented to participate 
5 refused to participate 
11 unable to complete assessments 
--6 discharged before assessment completed 
--5 too ill to conduct assessment 
21 had high scores 
on cognitive tasks 
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of the Shanghai Mental Health Center, one ward has 
50 beds with an average stay of 45 days and the other 
has 90 beds with an average stay of 60 days.  Patients 
were eligible to participate in the study if they were 
treated on one of the two wards from October 2010 to 
January 2011, were 18-55 years of age, had a current 
DSM-IV diagnosis of Schizophrenia or Schizoaffective 
Disorder, and did not have a co-morbid substance use 
disorder.  As shown in Figure 1, 40 of the 54 eligible 
patients completed the assessments of their clinical, 
cognitive and functional status. Their characteristics 
are presented in Table 1. They were primarily middle-
age males who had, on average, been ill for more 
than 20 years. All 40 patients were being treated 
with antipsychotic medication during the time of the 
assessment (35 on atypical antipsychotics, 1 on typical 
antipsychotics, and 4 on a combination of typical and 
atypical antipsychotics), and were clinically stable (i.e., 
not actively psychotic). 
All participants provided written informed consent. 
The study received institutional ethics approval from 
Deakin University and from the Shanghai Mental Health 
Center. 
2.2  Assessments
2.2.1    Clinical Symptoms and Social Functioning
All participants were rated on three clinical scales 
measuring symptoms, global functioning, and social 
functioning by one of two experienced psychiatrists (JZ, 
JH) trained in the consensus ratings of these measures.  
A Chinese version of the Positive and Negative 
Symptom Scales (PANSS)[25] was administered to 
all participants. The PANSS items were subdivided 
into three syndromes (reality distortion [5 items], 
psychomotor poverty [7 items] and disorganised 
[4 items]) based on Liddle’s 1987[15] description of these 
three syndromes of schizophrenia.  This method of 
categorizing symptoms was chosen because it has been 
supported by factor analysis of the PANSS[15,26,27] and 
been used in other studies examining neurocognition 
and symptoms in schizophrenia.[25]  In addition to the 
Liddle syndrome scores, we computed the total PANSS 
score (based on all 30 items) according to the  PANSS 
manual to allow comparison with other studies that 
have examined the reliability and validity of the Chinese 
version of the PANSS.[11,28]
The Clinical Global Impression Scale (CGI) is a 
widely used tool of global functioning that yields three 
measures; severity of illness, global improvement and 
an efficacy index.  It is widely used in China.[29,30] The 
Severity of Illness  (CGI-S) item requires clinicians to 
rate the severity of participants’ illness at the time of 
assessment on a 7-point scale, from 1 (normal, not at 
all ill) to 7 (among the most severely ill).  
Table 1. Demographic, clinical and cognitive characteristics of 40 male inpatients
               with schizophrenia included in the study
                                                                                                                             Mean              sd                     Range
Age (years) 46.2 8.3 22-56
Education (years) 10.7 2.1 9-24
Duration of Illness (years) 23.1 10.1 1-39
Chlorpromazine equivalent dose (mg/day) 422 350 11-1876
Clinical Global Impression-Severity (CGI-S) 4.5 1.0 2-6
Hong Kong List Learning Test (HKLT) 14.9 7.0 4-29
Letter-Number Sequencing Task (LNS) 2.6 1.6 0-6
Positive and Negative Symptom Scale (PANSS)
       PANSS Reality distortion 11.5 6.2 5-33
       PANSS Psychomotor poverty 20.2 5.8 7-35
       PANSS Disorganised 7.8 2.7 4-14
       PANSS Total 67.3 18.6 32-110
Personal and Social Performance Scale (PSP)
       PSP – Socially useful activities 4.1 0.6 3-5
       PSP – Personal and social relationships 3.8 0.9 2-5
       PSP – Self-care 2.2 0.9 1-5
       PSP – Disturbing and aggressive behaviour 2.0 1.2 1-6
       PSP – Overall Score 45.1 14.2 20-70
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The Personal and Social Performance Scale (PSP)[31] 
uses a 100-point rating scale to assesses four domains 
of social functioning including (a) socially useful 
activities, such as work and study; (b) personal and 
social relationships; (c) self-care; and (d) disturbing 
and aggressive behaviours.  The total score, which is a 
composite measure of the four domains, is divided into 
three levels:  a score of 71-100 indicates mild difficulties 
across the domains; 31-70 indicates varying degrees 
of impairment and disability; and 0-30 indicates 
poor functioning that requires intensive support 
or supervision. Assessment of a Chinese version of 
the PSP[28] in a combined sample of inpatients and 
outpatients demonstrated robust construct validity and 
good internal consistency (Cronbach’s alpha=0.84), test-
retest reliability (intraclass correlation coefficient=0.95) 
and inter-rater reliability (kappa value=0.82). However, 
the PSP has not previously been used exclusively with 
an inpatient sample.  
2.2.2  Cognitive assessments
Cognitive assessments were brief; they included 
a measure of verbal working memory and a measure 
of verbal memory and learning.  The letter-number 
sequencing task has established credentials and is a 
robust, yet quick and easily administered test of verbal 
working memory.[32] A Chinese version of this task[33] 
was used in the current study. The longest sequence 
achieved and total score were recorded. The longest 
sequence achieved was chosen as the variable of 
interest that was employed in the subsequent analysis 
as it best reflects working memory capacity.
The verbal memory task employed was Form 
B of the Hong Kong List Learning Test,[34] a Chinese 
verbal learning and memory test that has been well 
validated in a variety of populations including people 
with schizophrenia.[35] Form B has 16 words from four 
categories: clothing and accessories, music, flowers, 
and occupations.  Participants are informed about the 
four categories and about the total number of items 
before the names of the items are presented. After the 
researcher reads the words, participants are asked to 
recall as many of the items as possible (in any order). 
The total score for the test is used as the measure of 
verbal memory in the subsequent analysis.
These cognitive tasks were administered by a 
trained research assistant and took between 10 and 15 
minutes to complete. 
2.3  Statistical methods
The relationship of the three different types of 
measures—clinical, cognitive, and functional—was 
assessed using Pearson correlation coefficients. The 
internal consistency of the various measures was 
assessed using Cronbach’s alpha. The chlorpromazine-
equivalent daily dosage of the participants was not 
normally distributed so a log transformation of this 
variable was used in the statistical analyses.
To assess whether or not the relationship of 
cognitive functioning with social functioning varied 
for persons with different levels of impairment, we 
conducted a post-hoc analysis by splitting the sample 
based on whether they were 'high' or 'low' in cognitive 
functioning. This was achieved by forming a composite 
cognitive z-score for each participant from the two 
cognitive measures (LNS and HKLT) and then classifying 
the 21 patients with a positive composite z-score to the 
‘high’ cognitive functioning group and the 19 patients 
with a negative composite z-score to the ‘low’ cognitive 
functioning group.
3.  Results
Internal consistency of the three factor scores 
derived from the PANSS used in this analysis were as 
follows: reality distortion alpha=0.83, psychomotor 
poverty alpha=0.90; and disorganisation alpha=0.48. 
The internal consistency of the total PANSS score was 
0.915. Internal consistency of the overall PSP score 
using Cronbach’s alpha was 0.77.
Table 2 presents the bivariate Pearson’s product 
moment correlations of the symptom and cognitive 
variables with the PSP and CGI. Also included are 
possible confounding variables such as years of 
education and the log transformed medication dosage 
variable.  Spearman rho correlations produced a similar 
pattern so they are not reported here. Given that there 
are a large number of correlations considered, the level 
of statistical significance was set at 0.01 rather 0.05 to 
reduce the risk of Type 1 error.
The two cognitive variables (the Letter-Numbering 
Sequencing task and the Hong Kong List Learning Test) 
were not significantly related to any of the clinical or 
social functioning variables but they were positively 
related to the educational level of the participants. 
There was, however, a non-significant trend association 
between the working memory variable (LNS) and the 
disturbing or aggressive behaviour PSP subscale score 
(r=0.33, p=0.038). The two global functioning measures 
(CGI-S and the PSP total score) were both closely 
correlated with the three clinical measures derived from 
the PANSS (r-values all greater than 0.50) and strongly 
correlated with the overall PANSS score (r= -0.73, 
p<0.001). The score of the PSP subscale on personal 
and social relationships was also closely related to 
all three clinical measures. But the scores of the PSP 
subscales  on socially useful activities and self-care were 
only significantly related to the PANSS psychomotor 
poverty measure and the score of the PSP subscale on 
disturbing or aggressive behaviour was not significantly 
related to any of the clinical measures (though there 
was a trend correlation with all three clinical measures). 
We conducted a stratified post-hoc analysis (dividing 
the sample into those with high cognitive functioning 
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and low cognitive functioning) to assess whether or 
not the failure to identify a relationship between the 
cognitive measures and the functioning measures was 
due to the admixture of patients with widely differing 
cognitive states. No statistically significant relationships 
were found in the correlation analysis of cognitive 
measures with social functioning measures in either the 
high cognitive functioning group or the low cognitive 
Table 2. Pearson correlations and associated p-values of clinical, cognitive and social functioning variables in 40 inpatients with
               schizophreniaa
                                           
DEMOGRAPHIC       CLINICAL FACTORS                      SOCIAL FUNCTIONING FACTORS                             COGNITIVE                 
FACTORS                                                                                                                                                                             FACTORS
      (1)          (2)         (3)             (4)           (5)            (6)           (7)            (8)            (9)         (10)           (11)         (12)         (13)
DEMOGRAPHIC FACTORS
(1)Years of education
1 -.002 -.146 -.111 -.150 -.241 -.163 -.252 -.189 .063 .208 .426 .478
(.989) (.370) (.497) (.356) (.134) (.316) (.117) (.244) (.697) (.198) (.007) (.002)
(2)Log ransformation 
     of  CPZ-equivalent
     dose
1 -.148 .172 .023 .215 -.134 .082 .011 -.034 -.014 .047 -.189
(.364) (.289) (.888) (.183) (.409) (.614) (.949) (.836) (.931) (.776) (.250)
CLINICAL FACTORS
(3)Disorganized
     (from PANSS)
1 .453 .774 .596 .353 .549 .289 .398 -.505 -.055 -.158
(.003) (<.001) (<.001) (.026) (<.001) (.071) (.011) (.001) (.741) (.337)
(4)Reality distortion
     (from PANSS)
1 .370 .734 .241 .598 .241 .319 -.598 .037 -.020
(.019) (<.001) (.134) (<.001) (.134) (.045) (<.001) (.821) (.902)
(5)Psychomotor
     overty     (from PANSS)
1 .586 .481 .587 .441 .308 -.580 -.138 -.157




     Impression-
     Severity (CGI-S)
1 .581 .824 .391 .472 -.823 -.021 -.125
(<.001) (<.001) (.013) (.002) (<.001) (.897) (.449)
(7)Socially useful
     activities
     (from PSP)
1 .717 .332 .343 -.806 -.076 -.139
(<.001) (.036) (.030) (<.001) (.644) (.397)
(8)Personal and social
     relationships 
     (from PSP)
1 .477 .478 -.905 -.001 -.195
(.002) (.002) (<.001) (.993) (.233)
(9)Self-care
 
    (from PSP)
1 .566 -.555 .043 .017
(<.001) (<.001) (.795) (.918)
(10)Disturbing or
       aggressive 
       behaviour     
       (from PSP)







       sequencing task
       (LNS) 
1 .415
(.009)
(13)Hong Kong List 
       Learning Test 
       (HKLT)
1
PANSS= Positive and Negative Symptom Scale;  PSP= Personal and Social Performance Scale; CPZ=chlorpromazine
a Given the large number of correlations assessed, statistical significance is set at p<0.01. Statistically significant correlations are shown in bold.
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functioning group, though the relationship between the 
LNS score and the disturbing/aggressive PSP subscale 
score in the low cognitive functioning group was 
significant at a trend level (r=0.47, p=0.042). Moreover, 
there were no statistically significant differences 
between the high and low cognitive functioning groups 
in the magnitude of the correlation coefficients for 
the cognitive and functioning measures. (Data not 
presented).
4.   Discussion
4.1   Main Findings 
Our original hypotheses were not confirmed. In 
this sample of male inpatients with schizophrenia 
we found little evidence of a relationship between 
neurocognitive variables and either symptoms or 
functional measures, with the exception of a non-
significant trend relationship between decrements in 
verbal working memory performance and increased 
scores on the disturbing or aggressive behaviour 
subscale of the PSP. These findings are out of step 
with most prevailing literature in the area which has 
consistently found that verbal memory and, to a 
lesser extent, working memory are associated with 
functioning.[4] Our findings are, however, similar to 
the early findings of Addington and colleagues[9] who 
found no relationship between neurocognition and 
functioning (as assessed by the social dysfunction index 
and the social adjustment scale). They hypothesized 
that their negative findings were the result of specific 
characteristics of their sample; given the high level 
of impairment of the patients in their sample, they 
suggested that the relationship between neurocogntive 
variables and functional outcome may only hold true for 
higher functioning individuals. To assess this possibility 
we conducted a post-hoc analysis of our data dividing 
the sample into two groups, one group with relatively 
high cognitive functioning and one with relatively 
low cognitive functioning. We found no significant 
relationships between our cognitive measures (LNS and 
HKLT) and the social functioning PSP measures in either 
of the groups, so our results do not support Addington’s 
hypothesis.
We did, however, find robust correlations between 
all three symptom domains derived from the PANSS and 
our global functioning measures (CGI-S and overall PSP 
score). These correlations were substantially stronger 
than those reported by Patrick and colleagues;[36] they 
reported a correlation of PSP total score and PANSS 
total score of -0.32, versus the -0.73 correlation found 
in the current study. This difference may have occurred 
because our sample was less symptomatic at the time 
of assessment; unlike Patrick and colleagues we did 
not require elevated PANSS scores for inclusion in the 
study.  In our study the personal and social relationships 
subscale of the PSP was also closely associated with all 
three symptom domains. The relationship between the 
psychomotor poverty dimension of the PANSS and the 
personal and social relationships subscale of the PSP 
mirrors the findings of others.[37] 
4.2  Limitations
There were a number of limitations to our study. 
The modest sample size reduced the power to 
detect statistical significance. The large number of 
correlations presented in Table 2 (78 correlation 
coefficients) increased the possibility of Type I errors 
(i.e., inappropriately considering a chance difference as 
statistically significant). The three-factor model of the 
PANSS used in the study has not been validated in China 
and the internal consistency of the disorganization 
dimension of the PANSS was weak (alpha=0.48). Several 
of the items in the PSP related to social functioning 
were difficult to assess reliably in the inpatient setting; 
this may have resulted in a restriction in the range of 
scores of the related subscales. Only two relatively 
simple measures of neurocognitive functioning were 
included; a more comprehensive assessment would 
have provided more convincing proof of our finding 
of a lack of relationship between cognitive function 
and social function. The mean duration of illness of 
the sample was 23 years; the results may have been 
different for a less chronic sample. Finally, this is a 
cross-sectional study so we are only able to evaluate 
associations, not the cause-effect relationship of the 
variables considered.
4.3  Implications
The findings presented here add to the substantial 
body of work examining the relationships among 
neurocognition, symptoms and functional status in 
schizophrenia.  We failed to replicate what many others 
have found in regard to a strong relationship between 
neurocognition and functional status.  We also failed to 
replicate the common finding of a relationship between 
increased negative symptoms and poorer cognitive 
functioning.  It may be that this is the result of some 
limitations in the study such as too few neurocognitive 
variables or a small sample size. However, it may also be 
an indication that the extent to which neurocognition 
influences the social functioning of an individual 
is moderated by the severity of their psychological 
symptoms and the setting in which they are assessed. 
It appears, at least in this sample, that when individuals 
with schizophrenia are suffering from acute symptoms 
that require hospitalisation it is the symptoms, not 
neurocognitive variables, that are more important to 
personal and social functioning. Perhaps neurocognitive 
factors become more important as symptoms resolve. 
To test this idea one would need to follow patients 
over time and determine whether or not the relative 
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strength of the relationship between cognitive 
measures and personal and social functioning increases 
as the severity of clinical symptoms decreases. 
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表（Personal and Social Performance Scale，PSP）中文版、临床疗效总评量表-病情严重程度量表(Clinical Global 
Impression-Severity，CGI-S)、阳性和阴性症状量表(Positive and Negative Symptom Scale，PANSS)、字母-数字排序以
及香港文字记忆学习测试等项目的评定。
结果　患者PANSS量表的3个临床分量表的分值和社会功能总体评估(PSP总分和CGI-S分值)之间存在明显负相关。
患者的神经认知测定结果与症状或社会功能状况均无关。 
结论　对于急性期住院精神分裂症患者而言，临床症状的严重度—而非神经认知缺损程度，与其社会功能水平密
切相关。　
